Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.92
-
NAV
₹46.24
-
Fund Started
12 Nov 2018
-
Fund Size
₹3142.36 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
1 Year
8.65%
-
3 Year
22.02%
-
5 Year
14.30%
-
Equity
96.75%
-
Cash
3.25%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.84% |
Ipca Laboratories Ltd. | 8.26% |
Cipla Ltd. | 7.56% |
Globus Medical Inc | 7.35% |
Laurus Labs Ltd. | 6.42% |
Illumina Inc. (USA) | 6.16% |
Sai Life Sciences Ltd. | 6.10% |
Gland Pharma Ltd. | 5.13% |
Cohance Lifesciences Ltd. | 4.83% |
Apollo Hospitals Enterprise Ltd. | 4.73% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
